Follistatin 344 is a recombinant version of Follistatin, which is a naturally occurring glycoprotein due to a carbohydrate chain connected to its core, and its composition of 323 amino acids.
Follistatin is a glycoprotein made by folliculostellate cells (FS) in the anterior pituitary gland. This glycoprotein follows the autocrine signaling route.
An abnormally high cysteine concentration, a non-essential amino acid, in Follistatin 344 may contribute to the protein’s structure. Cysteine is what provides Follistatin 344 with its most distinguishing potential property, as outlined further below.
Follistatin-344 Peptide: Mechanism of Action
Studies suggest Follistatin 344 may employ a variety of mechanisms of action to stimulate the growth of muscle cells.
Myocytes, also known as muscle cells, are responsible for the production of myostatin [i], which is a growth and differentiation factor protein. The major purpose of myostatin is to perform the role of a regulator by putting a cap on the rate at which muscles may expand. This ensures that the muscles do not become unwieldy.
Research suggests Follistatin 344 may suppress myostatin activity. The inhibition of myostatin activity results from this subsequent blockage by Follistatin 344 [ii]. As a result, myostatin cannot function as a powerful inhibitor of the formation of muscle tissue.
Activin proteins may facilitate the production of follicle-stimulating hormone (FSH). On the other hand, an increase in follicle-stimulating hormone (FSH) levels in males are can lead to stunted muscle development and dysfunctional testicle functioning.
Findings imply Folistatin 344 may be responsible for the inhibition of activin, which may lead to a reduction in the hormone’s release. Researchers speculate Follistatin 344 may cause the granulosa cells to produce progesterone [iii] due to its action on those cells. Since progesterone is one of the primary hormones responsible for regulating the menstrual cycle, even modest changes in the amounts of this hormone may throw off the whole cycle.
Studies conducted on animals suggest that Follistatin may shorten the lives of cancer cells, slow their development, and lessen the likelihood of cancer spread [iv]. However, these findings have not been verified in clinical trials.
Follistatin 344 Peptide Research
Studies suggest Follistatin 344 may possibly reduce the amount of active myostatin, which leads to an increase in the rate at which muscle fibers multiply. When there is a greater proliferation of muscle cells, there is an increase in the total muscle mass.
One murine study exploring Follistatin 344 impacts on muscle, suggested that mice lacking myostatin appeared to have a 117% increase in the number of muscle fibers they exhibited. This suggests that the effects of Follistatin 344 on increasing muscle mass may also extend to other methods.
An abnormally high level of myostatin activity has links to a disease known as skeletal muscle fibrosis [v]. Research suggests that Follistatin 344 may possibly mitigate or even prevent the onset of this condition.
Studies conducted on mice have also suggested the peptide may impact fat storage. With findings suggesting that the peptide induced a considerable decrease in the amount of fat gained during the study period. Researchers speculate the alleged capability of Follistatin 344 to inhibit myostatin may be another factor that may be related.
Scientists hypothesize that Follistatin 344’s potential has another role. To bind to activin may also contribute to its potential to postpone the reproductive aging process. Because of its contact with granulosa cells, this glycoprotein is also responsible for regulating the process of ovulation. This connection causes the production of the hormone progesterone.
Studies suggest that the results of a biochemical examination of seminal fluid indicate a high concentration of Follistatin. Therefore, research suggests that presenting Follistatin 344 may potentially increase fertility.
Results from experiments conducted on mice suggest that Follistatin 344 may be useful in the mitigation of some subtypes of cancer. These results are perhaps the most groundbreaking so far.
Studies suggest that Follistatin 344 may give some protection against breast cancer. Another trial studying mice speculated that Follistatin may effectively mitigate the onset of metastasis in lung and ovarian cancer. In addition, researchers speculate it may allow for a rapid but successful recovery. Which is after tumor excision surgery on organs such as the liver [vi].
Follistatin 344 vs. IGF-1 LR3
Studies suggest IGF-1 LR3 may be useful because it may increase insulin sensitivity in muscle tissue. This leads to the development of new muscle tissue.
Even though Follistatin 344 operates differently, both proteins appear to work toward the same goal. That is, producing the properties described above.
Follistatin 344 vs. GHRP 6
The mechanism by which GHRP 6 exerts its effects is through binding to growth hormone secretagogue receptors (GHSr).
One of the most significant distinctions between the two peptides is the time between presentations. Researchers hypothesize that blending is the most useful method for progressing research findings. As both peptides’ impacts appear to work synergistically. If you are a licensed professional interested in further studying this substance, visit Core Peptides.
Read Also:
